Bronchial Asthma Clinical Trial
Official title:
Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Gabapentin Efficacy in Asthma Therapy
The purpose of this study is to determine whether antiepileptic drug gabapentin is effective in the treatment of chronic asthma.
Effective therapy of asthma still remains quite serious problem. According GINA definition,
asthma is an inflammatory disorder. Consequently, modern pharmacotherapy of asthma provides
wide use of anti-inflammatory drugs. But asthma also is a paroxysmal disorder: many
specialists and even some guidelines underline paroxysmal clinical picture of asthma.
Besides this, according to some authors, neurogenic inflammation may play important role in
asthma mechanism. But some other neurogenic inflammatory paroxysmal disorders exist, and
they are migraine and trigeminal neuralgia. Some antiepileptic drugs, like carbamazepine and
valproate, are very effective in therapy of migraine and trigeminal neuralgia - more than in
80% of cases. If bronchial asthma also is paroxysmal inflammatory disease, like migraine and
trigeminal neuralgia, it is possible that some antiepileptic drugs also are very effective
in asthma therapy.
We performed a double-blind, placebo-controlled 3-month trial for evaluation of gabapentin
efficacy in therapy of bronchial asthma. Gabapentin is antiepileptic drug of new generation,
produced by Pfizer.
Comparison: Patients received investigational drug in addition to their usual routine
antiasthmatic treatment, compared to patients received placebo in addition to their usual
routine antiasthmatic treatment.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02934945 -
Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients
|
Phase 4 | |
Completed |
NCT02561351 -
Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation
|
N/A | |
Recruiting |
NCT01759472 -
Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Effect Study of Montelukast to Treat Asthma Detected by LTD4 Bronchial Provocation Test
|
N/A | |
Completed |
NCT01918293 -
Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma): Adult
|
N/A | |
Completed |
NCT01203904 -
Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation
|
N/A | |
Completed |
NCT00536731 -
Symbicort Rapihaler Therapeutic Equivalence Study
|
Phase 3 | |
Completed |
NCT01762917 -
Influence of Bag Volume Variation on the Reproducibility of Inert Gas Rebreathing
|
N/A | |
Completed |
NCT00331929 -
Respiratory Health Study of Children in Kiryat Tivon
|
N/A | |
Completed |
NCT00930826 -
Childhood Asthma and Schooling: The Truth Unveiled
|
N/A | |
Completed |
NCT00327028 -
Study of Efficacy of Phenytoin in Therapy of Patients With Bronchial Asthma
|
Phase 4 | |
Completed |
NCT00413387 -
Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
|
Phase 3 | |
Completed |
NCT00950794 -
Study of Salmeterol (SN408D) for Adult Asthma
|
Phase 4 | |
Completed |
NCT00142025 -
Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma
|
Phase 4 | |
Completed |
NCT00153270 -
Study of Efficacy of Sodium Valproate in Therapy of Bronchial Asthma
|
Phase 4 | |
Completed |
NCT03450434 -
XC8 in the Treatment of Patients With Bronchial Asthma
|
Phase 2 | |
Recruiting |
NCT05189613 -
Mepolizumab Effectiveness in Severe Eosinophilic Asthma and Bronchiectasis
|
N/A | |
Recruiting |
NCT04128111 -
Study on the Correlation Between TCM Syndrome, Inflammatory Phenotype and Biomarker of Bronchial Asthma
|
||
Completed |
NCT06326632 -
Comparative Effectiveness Study of Constant-Load Versus Graded Aerobic Exercise in Obese Children With Bronchial Asthma
|
N/A | |
Completed |
NCT05088512 -
The Role of Genetic Factors in the Development of Bronchial Asthma in the Kazakh Population
|
||
Completed |
NCT01232322 -
Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation
|
N/A |